Dr. Arvind Kumar Shukla holds a B.Sc. in Zoology and Environmental Science from Mumbai University, an M.Sc. in Genetic Engineering from D.Y. Patil University, an MBA from D.Y. Patil Vidyapeeth (DPU) and a Ph.D. in Biomedical Convergence Engineering from Pusan National University. He is now a Research Fellow at the School of Biomedical Convergence Engineering, Pusan National University. He is actively engaged in researching various diseases such as cancer, regenerative medicine, HIV, cardiovascular disease, and more. His primary focus lies in the biofabrication of functional tissues and organ development through 3D bioprinting. Additionally, his research delves into cancer stem cell signaling pathways, including acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), colorectal cancer (CRC), breast cancer, and various types of solid cancers. He also investigates the efficacy of different cancer drugs through clinical testing for treatment.
Pusan National University
Busan, Republic of Korea
School of Biomedical Convergence Engineering

Outstanding Reviewer Award
MDPI
Awarded by Cancers in 2025